Terms: = Liver cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Clinical Outcome
4 results:
1. Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases.
Zhang C; Wang XY; Zuo JL; Wang XF; Feng XW; Zhang B; Li YT; Yi CH; Zhang P; Ma XC; Chen ZM; Ma Y; Han JH; Tao BR; Zhang R; Wang TQ; Tong L; Gu W; Wang SY; Zheng XF; Yuan WK; Kan ZJ; Fan J; Hu XY; Li J; Zhang C; Chen JH
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36759015
[TBL] [Abstract] [Full Text] [Related]
2. Anaplastic lymphoma kinase tyrosine kinase inhibitor-induced hepatic failure in lung cancer patients: A study of signal mining and analysis of the FDA adverse event reporting system database.
Zhou Z; Wang C; Ying L; Jin M; Zhang F; Shi D
J Clin Pharm Ther; 2021 Aug; 46(4):1148-1154. PubMed ID: 33768534
[TBL] [Abstract] [Full Text] [Related]
3. Long-term clinical outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.
Ageno W; Riva N; Schulman S; Beyer-Westendorf J; Bang SM; Senzolo M; Grandone E; Pasca S; Di Minno MN; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Oh D; D'Amico E; Becattini C; De Stefano V; Vidili G; Vaccarino A; Nardo B; Di Nisio M; Dentali F
JAMA Intern Med; 2015 Sep; 175(9):1474-80. PubMed ID: 26168152
[TBL] [Abstract] [Full Text] [Related]
4. Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases.
Durand-Zaleski I; Earlam S; Fordy C; Davies M; Allen-Mersh TG
Cancer; 1998 Sep; 83(5):882-8. PubMed ID: 9731890
[TBL] [Abstract] [Full Text] [Related]
